| BC | bladder cancer |
| BCG | bacillus Calmette–Guérin |
| BRIDGE | Bladder Cancer Research Initiative for Drug Targets Germany |
| CSS | cancer-specific survival |
| DFS EAU |
disease-free survival European Association of Urology |
| HPF | high power field |
| LA | lymphocyte aggregates |
| MD | medical doctor |
| MIBC | muscle-invasive bladder cancer |
| NMIBC | non-muscle-invasive bladder cancer |
| OS | overall survival |
| PFS | progression-free survival |
| RFS | recurrence-free survival |
| ROI | region of interest |
| TILs | tumor-infiltrating lymphocytes |
| TLS | tertiary lymphoid structures |
| TURB | transurethral resection of the bladder |
| WHO | World Health Organization |